HEMOPHILIA TREATMENT

Pfizer's stock took a hit recently, and it's all tied to a serious issue with one of their drugs. A patient in a long-term study for Hympavzi, a treatment for hemophilia, passed away due to severe complications. This news came out in December 2025, and it's got people talking. The patient had hemop

Pfizer Inc. has shared some exciting news! Their new medicine, HYMPAVZI (marstacimab-hncq), just got the green light from the U. S. Food and Drug Administration. This medication is designed to help people with hemophilia A and B prevent or reduce bleeding episodes. Hemophilia is a rare condition th